Scanning of the glucagon-like peptide-1 receptor localizes G protein- activating determinants primarily to the N terminus of the third intracellular loop

Molecular Endocrinology

Volumn 11, Issue 4, 1997, Pages 424-432

  Mathi, Swarna K ^a   Chan, Yvonne ^a   Li, Xinfang ^a   Wheeler, Michael B ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; INSULIN RELEASE; MOLECULAR INTERACTION; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN;

ANIMALIA;

EID: 0030990139     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.4.9913     Document Type: Article

References (35)

1. Fehmann HC, Goke G, Goke B 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide 1 and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390-410
2. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nature Med 2:1254-1258
3. Turton MD, O'Shea D, Gunn SA, Break CM, Edwards CMB, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JPH, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72
4. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W 1993 Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301-307
5. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S 1992 Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322
6. Ritzel R, Orskov C, Holst JJ, Nauck MA 1995 Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1(7-36 amide) after subcutaneous injection in healthy volunteers. Dose-response relationships. Diabetologia 38:720-725
7. Moens K, Heimberg H, Flamez D, Huyens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F 1996 Expression and functional activity of glucagon, glucagon-like peptide 1, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45:257-261
8. Orskov C, Poulsen SS 1991 Glucagon-like peptide-I-(7-36)-amide receptors only in islets of Langerhans. Diabetes 40:1292-1296
9. Thorens B 1992 Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89:8641-8645
10. Dillon JS, Tanizawa Y, Wheeler MB, Leng X-H, Ligon BB, Rabin DU, Warren HY, Permutt MA, Boyd III AE 1993 Cloning and functional expression of the human glucagon-like peptide (GLP-I) receptor. Endocrinology 133:1907-1910
11. Segre, G, Goldring, S 1993 Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagon-like peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein linked receptor family. Trends Endocrinol Metab 4:309-314
12. Wheeler M, Lu M, Dillon J, Leng X-H, Chen C, Boyd A 1993 Functional expression of the glucagon-like peptide-1(7-37) receptor: evidence for coupling to phosphoiipase C as well as adenylyl cyclase. Endocrinology 133:57-62
13. Holz G, Kuhtreiber WM, Habener JF 1993 Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361:362-365
14. Lu M, Wheeler M, Leng X-H, Boyd A 1993 The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37). Endocrinology 132:94-100
15. Widmann C, Burki E, Dolci W, Thorens B 1994 Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors and β-cell lines. Mol Pharmacol 45:1029-1035
16. Strader C, Fong T, Graziano M, Tota M 1995 The family of G protein coupled receptors. FASEB J 9:745-754
17. Hausdorf WP, Hnatowich M, O'Dowd BF, Caron MG, Lefkowitz RJ 1990 Mutational analysis of the β2-adrenergic receptor impairs agonist activation of adenylyl cyclase without affecting high affinity agonist binding. J Biol Chem 265:1388-1393
18. Hill-Eubanks D, Burstein ES, Spalding TA, Brauner-Osborne H, Brann MR 1996 Structure of a G-protein-coupling domain of a muscarinic receptor predicted by random saturated mutagenesis. J Biol Chem 271: 3058-3065
19. Laporte SA, Escher E, Gillemette G, Leduc R, The KAL KK sequence of the AT 1 receptor participates in receptor activation. Program of the 10th International Conference of Endocrinology, San Francisco, 1996 (Abstract P3-134)
20. Unson CG, Cypess AM, Kim HN, Goldsmith PK, Carruthers CJL, Merrifield RB, Sakmar TP 1995 Characterization of deletion and truncation mutants of the rat glucagon receptor. J Biol Chem 270:27720-27727
21. Widmann C, Dolci W, Thorens B 1996 Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate. Mol Endocrinol 10:62-75
22. Takhar S, Gyomorey S, Su RC, Mathi SK, Li X, Wheeler MB 1996 The third cytoplasmic domain of the tGLP-1 (7-36 amide) receptor is required for coupling to the adenylyl cyclase system. Endocrinology 137:2175-2178
23. Okamoto T, Kishimoto I 1992 Detection of G protein-activator regions in m4 subtype muscarinic, cholinergic, and a2-adrenergic receptors based upon characteristics in primary structure. J Biol Chem 267:8342-8346
24. Duerson, K, Carroll, R, Clapham, D 1993 α-Helical distorting substitutions disrupt coupling between m3 muscarinic receptor and G proteins. FEBS Lett 324:103-108
25. Bluml K, Mutschler E, Wess J 1994 Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. Proc Natl Acad Sci USA 91:7980-7984
26. Burstein ES, Spalding TA, Hill-Eubanks D, Brann MR 1995 Structure-function of the muscarinic receptor coupling to G proteins. J Biol Chem 270:3141-3146
27. Burstein E, Spalding T, Brann M 1996 Amino acid side chains that define muscarinic receptor/G-protein coupling. J Biol Chem 271:2882-2885
28. Heller R, Kieffer T, Habener J 1996 Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling. Biochem Biophys Res Commun 223:624-632
29. Gelling R, Van W, Su R-C, Mathi S, Gyomorey S, Pederson R, Macintosh C, Wheeler MB, The carboxy-terminal tail length of the rat islet glucose-dependent insulinotropic polypeptide is important for efficient expression at the membrane level, activation of adenylyl cyclase. Program of the 11th International Conference on Regulatory Peptides, Copenhagen, Denmark, 1996 (Abstract)
30. Huang Z, Chen Y, Pratt S, Chen TH, Bambino T, Shoback DM, Nissenson RA 1995 Mutational analysis of the cytoplasmic tail of the G protein coupled receptor for parathyroid hormone (PTH) and PTH-related protein: effects on receptor expression and signaling. Mol Endocrinol 9:1240-1249
31. Kunkel T 1985 Rapid and efficient site-specific mutagenesis without phenotype selection. Proc Natl Acad Sci USA 82:488-492
32. Kunkel, T 1987 Rapid and efficient site-specific mutagenesis without phenotype selection. Methods Enzymol 154:367-382
33. Wheeler MB, Lu M, Boyd AE 1993 The rat glucagon-like peptide 1 receptor can couple to adenylate cyclase, PLC, and the free cytosolic calcium level. Digestion 54:348-349
34. Keen M, MacDermot J, 1993 Analysis of receptors by radioligand binding. In: Worten J, Polak J (eds) Receptor Autoradiography: Principles and Practice. Oxford University Press, Oxford, U.K., pp 23-55
35. Whaley BS, Nanyong Y, Birnbaumer L, Clark RB, Barber R 1994 Differential expression of the β-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Mol Pharmacol 45:481-489